INBX
Inhibrx Biosciences, Inc.
NASDAQ: INBX · HEALTHCARE · BIOTECHNOLOGY
$129.21
+3.52% today
Updated 2026-04-30
Market cap
$1.82B
P/E ratio
—
P/S ratio
1,402.52x
EPS (TTM)
$-9.04
Dividend yield
—
52W range
$11 – $155
Volume
0.3M
Inhibrx Biosciences, Inc. (INBX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |